Related Experiment Video
Updated: Jul 26, 2026

Measuring Global Cellular Matrix Metalloproteinase and Metabolic Activity in 3D Hydrogels
Published on: January 22, 2019
Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development
C V Hojilla1, F F Mohammed, R Khokha
1Ontario Cancer Institute, University Health Network, Toronto, Canada.
Abstract:
Matrix metalloproteinases (MMPs) were initially recognised for their extracellular matrix (ECM)-degrading capability during tissue remodelling. Their importance was further highlighted by their role in metastasis. Clinical trials have since evaluated the potential of MMP inhibitors as anticancer therapeutics, but without success. These initial studies point to the complex, multifunctional capacity of MMPs in cancer as shown by their function, not only as strident mediators of advanced malignancies, but also as effectors of early stage tumorigenesis. Research now shows that MMPs, and their tissue inhibitors, affect tumour initiation and growth through loss of cell adhesion, evasion of apoptosis, and deregulation of cell division. The extracellular nature of the metalloproteinase axis situates it as a master regulator of cell fate.
Insights
Matrix metalloproteinases (MMPs) are crucial in cancer, impacting tissue remodelling and metastasis. Despite failed clinical trials for MMP inhibitors, research reveals MMPs regulate tumor initiation and growth through cell adhesion, apoptosis, and division.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Matrix metalloproteinases (MMPs) are enzymes involved in extracellular matrix (ECM) degradation and tissue remodeling.
- MMPs play a significant role in cancer metastasis.
- Previous attempts to use MMP inhibitors as anticancer therapeutics have been unsuccessful.
Purpose of the Study:
- To explore the multifaceted roles of MMPs in cancer, beyond their matrix-degrading functions.
- To investigate how MMPs influence early-stage tumorigenesis and advanced malignancies.
- To understand the mechanisms by which MMPs and their inhibitors affect tumor initiation and progression.
Main Methods:
- Review of existing literature on MMPs in cancer.
- Analysis of studies investigating MMPs' roles in cell adhesion, apoptosis, and cell division.
- Examination of the extracellular functions of the metalloproteinase axis.
Main Results:
- MMPs exhibit complex, multifunctional roles in cancer, acting as effectors in early tumorigenesis and mediators of advanced malignancies.
- MMPs and their tissue inhibitors influence tumor initiation and growth by affecting cell adhesion, promoting apoptosis evasion, and deregulating cell division.
- The extracellular nature of MMPs positions them as key regulators of cell fate in cancer.
Conclusions:
- MMPs are critical regulators of cancer progression, with implications for both tumor initiation and metastasis.
- The complex roles of MMPs necessitate a deeper understanding for potential therapeutic strategies.
- Targeting the metalloproteinase axis offers a promising avenue for cancer research and treatment development.
More Related Videos
Related Concept Videos
Mitogens and the Cell Cycle
The Tumor Microenvironment
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Role of Matrix Metalloproteases in Degradation of ECM
A...
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...

